| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |